We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Alzheimer's

News List

Biogen, Eisai's anti-amyloid drug slows Alzheimer's decline, but debate rages on fiercebiotech
July 30, 2018
Biogen and Eisai revealed data from an 800-patient trial showing their amyloid-fighting antibody significantly slowed cognitive decline and amyloid buildup in the brain. The findings are a first in a field rife with prospects that show early promise but f
Eisai, Biogen’s Alzheimer’s candidate shows promise in PhII trial pharmatimes
July 09, 2018
At last some good news for Alzheimer’s research, as Eisai and Biogen’s experimental anti beta-amyloid therapy BAN2401 hit targets in a Phase II trial in patients with the disease.
New leads on treating dementia and Alzheimer's worldpharmanews
May 11, 2018
A new research study by scientists in Australia and the US provides an explanation for why clinical trials of drugs reducing proteins in the brain that were thought to cause dementia and Alzheimer's have failed.
Nanoparticle imaging startup Alzeca reels in $11M for Alzheimer's diagnostic fiercebiotech
August 18, 2017
Alzeca will use its series A funding to carry its nanoparticle contrast agent through a phase 1 trial.